Has any research been done investigating possible means of reducing the rate
of mtDNA mutation? please explain
Often both the clinician and the prospective heteroplasmic mother will use PND, or more so PGD, to identify embryos harbouring absolutely none of the pathogenic mtDNA mutation. It is also possible to select for fetuses and embryos, and thus prevent disease in the next generation and subsequent transmission.7
Comments
Leave a comment